[go: up one dir, main page]

WO2007063129A3 - Insolation of peptides , polypeptides and proteins - Google Patents

Insolation of peptides , polypeptides and proteins Download PDF

Info

Publication number
WO2007063129A3
WO2007063129A3 PCT/EP2006/069208 EP2006069208W WO2007063129A3 WO 2007063129 A3 WO2007063129 A3 WO 2007063129A3 EP 2006069208 W EP2006069208 W EP 2006069208W WO 2007063129 A3 WO2007063129 A3 WO 2007063129A3
Authority
WO
WIPO (PCT)
Prior art keywords
insolation
polypeptides
peptides
proteins
protein
Prior art date
Application number
PCT/EP2006/069208
Other languages
French (fr)
Other versions
WO2007063129A2 (en
Inventor
Bjarke Christensen
Allan Noergaard
Original Assignee
Novozymes As
Upfront Chromatography As
Bjarke Christensen
Allan Noergaard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As, Upfront Chromatography As, Bjarke Christensen, Allan Noergaard filed Critical Novozymes As
Publication of WO2007063129A2 publication Critical patent/WO2007063129A2/en
Publication of WO2007063129A3 publication Critical patent/WO2007063129A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides a process for the isolation of rHSA from a protein solution. The process comprising the steps of: a) providing a protein solution comprising one or more specific protein(s) and having a preset pH and a preset ionic strength or conductivity, b) applying the protein solution to a packed bed or expanded bed column comprising an adsorbent, and c) obtaining one or more protein(s) from the column.
PCT/EP2006/069208 2005-12-02 2006-12-01 Insolation of peptides , polypeptides and proteins WO2007063129A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200501713 2005-12-02
DKPA200501713 2005-12-02
DKPA200501738 2005-12-07
DKPA200501738 2005-12-07

Publications (2)

Publication Number Publication Date
WO2007063129A2 WO2007063129A2 (en) 2007-06-07
WO2007063129A3 true WO2007063129A3 (en) 2007-07-12

Family

ID=37770284

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/069208 WO2007063129A2 (en) 2005-12-02 2006-12-01 Insolation of peptides , polypeptides and proteins

Country Status (1)

Country Link
WO (1) WO2007063129A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106661587A (en) * 2014-01-31 2017-05-10 法纳生物解决办法有限责任公司 Expression and purification of CRM197 and related proteins

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5600061B2 (en) * 2007-08-17 2014-10-01 ツェーエスエル ベーリンク ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for purifying α-1-antitrypsin and apolipoprotein AI
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
CN102533553B (en) * 2011-12-29 2013-06-26 湖南省微生物研究所 Organic matter decomposition combined fungicide for rapidly degrading rice straws and application method thereof
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US11060123B2 (en) 2014-01-31 2021-07-13 Fina Biosolutions, Llc Production of soluble recombinant protein without n-terminal methionine
US12104161B2 (en) 2014-01-31 2024-10-01 Fina Biosolutions Llc Production of soluble recombinant proteins without N-terminal methionine in E-coli
CN109182145B (en) * 2018-09-29 2021-05-11 武汉友芹种苗技术有限公司 Aspergillus aculeatus strain and application thereof
KR20240140179A (en) * 2022-02-11 2024-09-24 클라라 푸드즈 컴퍼니 Protein composition and consumable products thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0699687A2 (en) * 1994-08-31 1996-03-06 The Green Cross Corporation Process for purifying recombinant human serum albumin
WO2000044772A2 (en) * 1999-01-30 2000-08-03 Delta Biotechnology Limited Human serum albumin
WO2005121163A2 (en) * 2004-06-07 2005-12-22 Upfront Chromatography A/S Isolation of plasma or serum proteins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0699687A2 (en) * 1994-08-31 1996-03-06 The Green Cross Corporation Process for purifying recombinant human serum albumin
WO2000044772A2 (en) * 1999-01-30 2000-08-03 Delta Biotechnology Limited Human serum albumin
WO2005121163A2 (en) * 2004-06-07 2005-12-22 Upfront Chromatography A/S Isolation of plasma or serum proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GOUKA R J ET AL: "Efficient production of secretedproteins by Aspergillus: progress, limitations and prospects", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 47, no. 1, January 1997 (1997-01-01), pages 1 - 11, XP002121584, ISSN: 0175-7598 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106661587A (en) * 2014-01-31 2017-05-10 法纳生物解决办法有限责任公司 Expression and purification of CRM197 and related proteins

Also Published As

Publication number Publication date
WO2007063129A2 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
WO2005121163A3 (en) Isolation of plasma or serum proteins
WO2007063129A3 (en) Insolation of peptides , polypeptides and proteins
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
WO2010011313A3 (en) Ligation of stapled polypeptides
WO2006127757A3 (en) Interferon-igg fusion
WO2009147248A3 (en) Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
WO2007036299A3 (en) Method for amidating polypeptides with basic aminoacid c- terminals by means of specific endoproteases
WO2003102132A3 (en) Non-affinity purification of proteins
AU2016222301A1 (en) Isolation and purification of antibodies using Protein A affinity chromatography
WO2002016412A3 (en) Binding polypeptides for b lymphocyte stimulator protein (blys)
WO2005047511A3 (en) Bacterial expression of protease inhibitors and variants thereof
PL1789434T3 (en) Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
WO2005050224A3 (en) Small molecule and peptide arrays and uses thereof
ES2379283T3 (en) Serum albumin binding proteins
IL187168A (en) Proteins or polypeptides which comprise two identical nanobodies against von willebrand factor, methods for their preparation, pharmaceutical compositions comprising them and their uses
WO2007075438A3 (en) Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
WO2007075283A3 (en) Polishing steps used in multi-step protein purification processes
WO2008157378A3 (en) Rage fusion proteins
WO2004069211A3 (en) Affinity proteins for controlled application of cosmetic substances
WO2008076487A3 (en) Antibodies and methods for making and using them
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2005067601A3 (en) Vectors for recombinant protein expression in e.coli
WO2005016127A3 (en) Prion-specific peptide reagents
GB0100513D0 (en) Process

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06830275

Country of ref document: EP

Kind code of ref document: A2